Workflow
Palo Alto(PANW) - 2025 Q3 - Quarterly Report
2025-05-20 23:01
Financial Performance - Total revenue for Q3 fiscal 2025 was $2.3 billion, a year-over-year growth of 15.3% compared to $2.0 billion in Q3 fiscal 2024[113] - Product revenue reached $452.7 million, accounting for 19.8% of total revenue, with a year-over-year growth of 15.8%[114] - Subscription and support revenue grew to $1.8 billion, representing 80.2% of total revenue, with a year-over-year growth of 15.2%[114] - Total revenue for the three months ended April 30, 2025, was $2,289.0 million, representing a year-over-year increase of 15.3%[124] - Subscription and support revenue for the three months ended April 30, 2025, was $1,836.3 million, a 15.2% increase from $1,593.8 million in the same period last year[130] - Product revenue for the three months ended April 30, 2025, was $452.7 million, reflecting a 15.8% increase from $391.0 million in the prior year[128] - Net income for the three months ended April 30, 2025, was $262.1 million, which is 11.5% of total revenue[125] - Total gross profit for the three months ended April 30, 2025, was $1,669.7 million, with a gross margin of 72.9% compared to 74.1% in the same period in 2024[139] Expenses and Margins - Gross margin for the three months ended April 30, 2025, was 72.9%, down from 74.1% in the same period last year[124] - Operating income for the three months ended April 30, 2025, was $218.8 million, with an operating margin of 9.6%[124] - Total operating expenses for the three months ended April 30, 2025, were $1,450.9 million, representing 63.3% of total revenue[125] - Research and development expenses for the three months ended April 30, 2025, were $494.5 million, an increase of $37.3 million or 8.2% compared to the same period in 2024[143] - Sales and marketing expenses for the three months ended April 30, 2025, were $718.7 million, a decrease of $73.8 million or 10.3% compared to the same period in 2024[145] - General and administrative expenses for the three months ended April 30, 2025, were $118.6 million, a decrease of $45.3 million or 38.2% compared to the same period in 2024[147] Cash Flow and Investments - Free cash flow (non-GAAP) for the nine months ended April 30, 2025, was $2,535.3 million, compared to $2,635.5 million in the prior year[122] - Cash flow provided by operating activities for the nine months ended April 30, 2025, was $2,695.2 million, slightly down from $2,744.9 million in the previous year[122] - Cash provided by operating activities was $2.7 billion for the nine months ended April 30, 2025, a slight decrease of $49.7 million compared to the same period in 2024[167] - Cash used in investing activities increased by $100.8 million to $1.4 billion for the nine months ended April 30, 2025, primarily due to higher purchases of investments[169] - Cash used in financing activities decreased by $759.0 million to $404.8 million for the nine months ended April 30, 2025, mainly due to reduced cash used for share repurchases[171] - Total cash, cash equivalents, and investments reached $8.5 billion as of April 30, 2025, up from $6.8 billion as of July 31, 2024[154] Strategic Initiatives - In April 2025, the company introduced new offerings such as Prisma AIRS and Cortex XSIAM 3.0, and announced the acquisition of Protect AI, expected to close by Q1 fiscal 2026[115] - The company focuses on a platformization strategy to simplify security architectures and consolidate various products and services[108] - The AI-driven Cortex platform enhances security operations with unified data and automation, providing real-time prevention and automated remediation[110] - The company emphasizes the importance of innovation and timely development of new features to meet end-customer needs and improve competitive positioning[115] Market and Economic Conditions - The company continues to monitor macroeconomic conditions, including inflation and geopolitical tensions, which may impact business performance[117] - The company maintains a two-tiered indirect fulfillment model for sales, working closely with channel partners[113] - Revenue from the Americas increased by $169.6 million or 12.5% for the three months ended April 30, 2025, contributing the highest increase in revenue due to its larger scale[131] Accounting and Financial Estimates - The company has made significant estimates and assumptions regarding goodwill and intangible assets in business combinations, impacting future amortization expenses[174] - A hypothetical 100 basis point increase in interest rates would result in a $124.7 million decline in the fair market value of the investment portfolio[178] - The company maintains a diversified portfolio of cash, cash equivalents, and investment-grade securities to minimize interest rate risk[178] - There have been no significant changes to critical accounting estimates since the last report, except for updates related to the acquisition of certain IBM QRadar assets[173] - The company evaluates its estimates and assumptions on an ongoing basis, acknowledging that actual results could differ materially due to economic uncertainties[172] - Contingent consideration obligations in business combinations are subject to revaluation at the end of each reporting period, which may materially impact future fair values[175] - The company aims to preserve principal, provide liquidity, and maximize income without significantly increasing risk in its investment activities[178] - Recent accounting pronouncements have been reviewed, with expectations of their impact on results of operations and financial condition noted[176] - The company assesses its exposures to market risk, with no material changes reported since the last annual report[177] - Critical estimates in valuing intangible assets include expected future cash flows, discount rates, and profit margins[174]
ZTO EXPRESS(ZTO) - 2025 Q1 - Quarterly Results
2025-05-20 22:00
Financial Performance - Parcel volume increased by 19.1% year over year to 8.5 billion[1] - Adjusted net income grew by 1.6% to RMB2.3 billion[1] - Total revenues reached RMB10,891.5 million (US$1,500.9 million), an increase of 9.4% from RMB9,960.0 million in the same period of 2024[4] - Net income increased by 40.9% to RMB2,039.2 million (US$281.0 million) compared to RMB1,447.7 million in the same period of 2024[21] - Adjusted EBITDA rose by 0.7% to RMB3,686.7 million (US$508.0 million) from RMB3,660.4 million in the same period of 2024[23] - Revenue from core express delivery services increased by 9.8%, driven by a 19.1% growth in parcel volume[9] - KA revenue surged by 129.3% due to an increase in e-commerce return parcels[9] - Basic and diluted earnings per ADS were RMB2.50 (US$0.34), an increase of 41.2% from RMB1.77 in the same period of 2024[22] Cost and Expenses - Total cost of revenues increased by 17.9% to RMB8,202.2 million (US$1,130.3 million) from RMB6,957.9 million in the same period last year[10] - Gross profit for the same period decreased to RMB 2,689,220 (US$370,584) from RMB 3,002,085[43] Guidance and Future Expectations - The company reiterated its annual volume guidance to grow by 20%-24%[1] - The company expects parcel volume in 2025 to be between 40.8 billion and 42.2 billion, reflecting a year-over-year growth of 20% to 24%[28] Shareholder Returns - The company has approved a share repurchase program with an aggregate value of US$2.0 billion, with US$771.7 million remaining as of March 31, 2025[26] - The share repurchase program extension to June 30, 2026, reflects the company's confidence in market opportunities and financial strength[27] Cash Flow and Assets - Net cash provided by operating activities rose from RMB 2,031,020 thousand in Q1 2024 to RMB 2,362,976 thousand in Q1 2025, an increase of 16.3%[46] - Cash, cash equivalents, and restricted cash decreased from RMB 13,530,947 thousand at the beginning of Q1 2025 to RMB 12,461,807 thousand at the end of the period, a decline of 7.9%[46] - The company reported a net decrease in cash, cash equivalents, and restricted cash of RMB 1,069,140 thousand during Q1 2025[46] - The company experienced a net cash used in investing activities of RMB 3,158,465 thousand in Q1 2025, compared to RMB 2,378,652 thousand in Q1 2024, reflecting a significant increase of 32.7%[46] Assets and Liabilities - Total current assets increased slightly from RMB 30,353,721 thousand as of December 31, 2024, to RMB 30,570,788 thousand as of March 31, 2025, representing a growth of 0.72%[44] - Total liabilities increased from RMB 29,665,497 thousand as of December 31, 2024, to RMB 30,283,714 thousand as of March 31, 2025, marking a rise of 2.1%[44] - Total assets grew from RMB 92,340,330 thousand as of December 31, 2024, to RMB 93,149,512 thousand as of March 31, 2025, an increase of 0.88%[44] Income Attribution - Net income attributable to ZTO Express (Cayman) Inc. for the three months ended March 31, 2025, was RMB 1,993,247 (US$274,675), up from RMB 1,426,046 in 2024[43] - Net income attributable to ordinary shareholders increased from RMB 1,426,046 thousand in Q1 2024 to RMB 1,993,247 thousand in Q1 2025, reflecting a growth of 39.7%[48] - Basic net earnings per share attributable to ordinary shareholders increased from RMB 1.77 in Q1 2024 to RMB 2.50 in Q1 2025, a growth of 41.2%[48] Non-GAAP Measures - The company utilizes non-GAAP financial measures such as EBITDA and adjusted net income for evaluating operating results[30] - Adjusted EBITDA for Q1 2025 was RMB 3,686,680 thousand, up from RMB 3,660,367 thousand in Q1 2024, indicating a marginal increase of 0.72%[48] Operational Model - The company operates a scalable network partner model to support e-commerce growth in China[39]
SHF (SHFS) - 2025 Q1 - Quarterly Report
2025-05-20 21:51
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________to _________ Commission File Number 001-40524 SHF Holdings, Inc. (Exact name of registrant as specified in Its charter) | Delaware | 86-2409612 | | --- | --- | ...
Bayview Acquisition Corp(BAYAU) - 2025 Q1 - Quarterly Report
2025-05-20 21:50
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number 001-41890 BAYVIEW ACQUISITION CORP (Exact name of registrant as specified in its charter) Cayman Islands N/A (S ...
Bayview Acquisition(BAYA) - 2025 Q1 - Quarterly Report
2025-05-20 21:50
BAYVIEW ACQUISITION CORP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number 001-41890 (Exact name of registrant as specified in its charter) Cayman Islands N/A (S ...
Nubia Brand International (NUBI) - 2025 Q1 - Quarterly Report
2025-05-20 21:41
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-41323 SOLIDION TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) | Delaware | 87-1993879 | | --- ...
Solidion(STI) - 2025 Q1 - Quarterly Report
2025-05-20 21:41
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-41323 SOLIDION TECHNOLOGY, INC. (Exact name of registrant as specified in its charter) | Delaware | 87-1993879 | | --- ...
Nuburu(BURU) - 2025 Q1 - Quarterly Report
2025-05-20 21:28
Financial Performance - The Company generated total revenue of $93,549 for the three months ended March 31, 2024, compared to nil revenue for the same period in 2025, resulting in net losses of $5,705,098 and $14,020,050 respectively[172]. - Revenue decreased by $93,549 during the three months ended March 31, 2025, compared to the same period in 2024, primarily due to cost reduction measures including employee furloughs[225]. - The net loss for the three months ended March 31, 2025, was $(14,020,050), compared to $(5,705,098) in the same period in 2024, reflecting an increase in loss of $2,083,098[225]. - The company incurred net losses of $14,020,050 and $5,705,098 for Q1 2025 and Q1 2024, respectively, with an accumulated deficit of $135,428,605 as of March 31, 2025[241]. Operating Expenses - Total operating expenses were $2,806,705 for the three months ended March 31, 2025, down from $3,764,880 in the same period in 2024, reflecting a reduction of $958,175[225]. - Cost of revenue decreased by $621,239 during the three months ended March 31, 2025, attributed to a decrease of approximately $468,000 in direct labor and job costs and $120,000 in overhead[226]. - Research and development expenses decreased by $581,932 during the three months ended March 31, 2025, mainly due to lower personnel costs from the furlough of employees[227]. - Selling and marketing expenses increased by $197,747 during Q1 2025 compared to Q1 2024, primarily due to a $230,000 increase in professional and consulting expenses[228]. - General and administrative expenses decreased by $573,990 during Q1 2025 compared to Q1 2024, driven by a $512,000 decrease in payroll costs[229]. Cash Flow and Financing Activities - Cash and cash equivalents decreased to $70,937 as of March 31, 2025, down from $209,337 as of December 31, 2024[240]. - Net cash used in operating activities was $1,927,792 for Q1 2025, a decrease from $2,093,442 in Q1 2024[250]. - Net cash provided by financing activities was $2,539,392 for Q1 2025, compared to $176,627 in Q1 2024[253]. Debt and Liabilities - The operating loss for the three months ended March 31, 2025, included $10,398,050 of non-cash interest expense recognized on remeasurement of preferred stock liability[172]. - The company recorded a loss on extinguishment of debt amounting to $(3,386,416) during the three months ended March 31, 2025[225]. - Interest expense decreased significantly by $998,382, from $(1,191,862) in the three months ended March 31, 2024, to $(193,480) in the same period in 2025[225]. - Interest expense decreased by $998,382 during Q1 2025 compared to Q1 2024, primarily due to lower debt balances[230]. Investments and Commitments - The Company has entered into a commitment letter with Trumar Capital LLC to acquire a controlling interest in a defense-tech company and a SaaS startup, with the first stage of investment completed at $1.5 million[186][187]. - The Company entered into a convertible facility with Supply@ME Capital Plc with a capacity of up to $5.15 million, of which $150,000 was funded as of March 31, 2025[189]. - The Company issued a $525,000 face amount secured promissory note to Agile Capital Funding for a capital infusion of $500,000, requiring weekly repayments totaling $756,000[196]. - The Company issued a $227,700 face amount convertible promissory note to 1800 Diagonal Lending LLC for a capital infusion of $188,000, with additional financing of up to $2,275,000 expected[197]. Compliance and Regulatory Issues - As of March 31, 2025, the Company was in default under its lease, resulting in a default judgment against the Company in the amount of $409,278[176]. - The Company received a Notice of Noncompliance from NYSE Regulation for not maintaining stockholders' equity of $2.0 million or more, with a compliance plan due by May 29, 2025[179][180]. - The company anticipates incurring net losses for the foreseeable future and raises substantial doubt about its ability to continue as a going concern[242]. Other Financial Metrics - The company recorded a gain on the sale of intellectual property intangible assets at $8,961,872 during the three months ended March 31, 2025[225]. - The company recorded a gain of $127,300 on the change in fair value of warrant liabilities during Q1 2025, compared to a gain of $3,311 in Q1 2024[232]. - EBITDA excludes certain recurring, non-cash charges, and does not reflect cash requirements for asset replacements or new capital expenditures[267]. - Free cash flow does not account for the impact of equity or debt raises, debt repayments, or dividends paid[267]. Accounting Policies - There have been no significant changes to the company's accounting policies during the three months ended March 31, 2025[266]. - As of March 31, 2025, the company has no off-balance sheet arrangements, obligations, assets, or liabilities[263]. - The company has not entered into any off-balance sheet financing arrangements or established special purpose entities[263]. - The company is classified as a smaller reporting company and is not required to provide extensive market risk disclosures[270].
Drugs Made In America Acquisition Corp(DMAA) - 2025 Q1 - Quarterly Report
2025-05-20 21:28
IPO and Fundraising - The company completed its Initial Public Offering (IPO) on January 29, 2025, raising gross proceeds of $200 million from the sale of 20 million units at $10.00 per unit[104]. - An additional 3 million units were sold through the over-allotment option, generating an extra $30 million in gross proceeds[106]. - The total amount placed in the trust account after the IPO and private placements was $231,150,000[115]. - The company incurred transaction costs of $8,898,201 related to the IPO, including $1,150,000 in cash underwriting fees[117]. - The underwriters received a cash underwriting discount of $1,150,000, which is 0.5% of the gross proceeds from the Initial Public Offering[126]. - A deferred fee of $6,900,000, or 3.0% of the gross proceeds from the Initial Public Offering, is contingent upon completing a business combination[126]. Financial Performance - As of March 31, 2025, the company reported a net income of $1,254,543, primarily from interest earned on cash and investments held in the trust account[112]. - The company has not generated any operating revenues to date and does not expect to do so until after completing its initial business combination[111]. - Management has raised substantial doubt about the company's ability to continue as a going concern within one year due to mandatory liquidation considerations[123]. Business Operations and Plans - The company has a 15-month period to complete its initial business combination, which can be extended by up to 6 months with sponsor deposits[108]. - The company intends to use the funds in the trust account primarily for the initial business combination and related operational expenses[118]. - The company has a subscription promissory note allowing it to borrow up to $1,100,000 for working capital, which may convert into Private Placement Units[116]. Financial Obligations and Risks - As of March 31, 2025, the company has no off-balance sheet financing arrangements or obligations with unconsolidated entities[124]. - The company has no long-term debt or capital lease obligations, with a monthly payment of $10,000 for administrative services[125]. - Due to the short-term nature of these investments, the company anticipates no material exposure to interest rate risk[129]. Accounting and Compliance - The company has not identified any critical accounting estimates that could materially affect financial statements[127]. - Management believes that recently issued accounting standards will not have a material effect on the unaudited financial statements[128]. - Following the Initial Public Offering, net proceeds have been invested in U.S. government treasury obligations with a maturity of 185 days or less[129].
Luminar Technologies(LAZR) - 2025 Q1 - Quarterly Report
2025-05-20 21:28
Financial Performance - Total revenue for Q1 2025 was $18,886,000, a decrease of 10% compared to $20,968,000 in Q1 2024[18] - Net loss for Q1 2025 was $80,691,000, compared to a net loss of $125,714,000 in Q1 2024, representing a 36% improvement[18] - For the three months ended March 31, 2025, the company reported a net loss of $80.7 million, an improvement from a net loss of $125.7 million in the same period of 2024, representing a 35.8% reduction in losses[25] - The basic and diluted loss per share for Q1 2025 was $(1.92), significantly improved from $(4.44) in Q1 2024[134] - The operating loss for the total company was $72.272 million, with Autonomy Solutions reporting a loss of $67.480 million and ATS a loss of $4.792 million[174] Expenses and Costs - Operating expenses decreased to $64,172,000 in Q1 2025, down 44% from $115,314,000 in Q1 2024[18] - Research and development expenses for Q1 2025 were $38,288,000, a decrease of 44% from $67,750,000 in Q1 2024[18] - Stock-based compensation expense totaled $19.380 million for the three months ended March 31, 2025, down from $44.465 million in 2024[160] - The company incurred $9.8 million in total charges associated with employee severance and related costs through March 31, 2025, as part of its restructuring efforts[194] Cash and Liquidity - Cash and cash equivalents decreased to $59,322,000 as of March 31, 2025, down from $82,840,000 as of December 31, 2024[16] - As of March 31, 2025, the company had total liquidity of $138.2 million, consisting of $59.3 million in cash and cash equivalents and $78.9 million in marketable securities[32] - The company utilized $44.2 million in cash for operating activities during the same period, compared to $81.2 million in the prior year, indicating a 45.6% decrease in cash used[25] Assets and Liabilities - Total assets decreased to $319,449,000 as of March 31, 2025, from $365,213,000 as of December 31, 2024[16] - Total liabilities slightly decreased to $581,119,000 as of March 31, 2025, from $586,002,000 as of December 31, 2024[16] - The company’s accumulated deficit increased to $2,193,526,000 as of March 31, 2025, compared to $2,112,835,000 as of December 31, 2024[16] Revenue Concentration - The company’s revenue is significantly concentrated, with three customers accounting for 44%, 14%, and 13% of accounts receivable as of March 31, 2025[39] - North America accounted for 79% of total revenue in Q1 2025, down from 97% in Q1 2024, while Europe and the Middle East increased to 19% from 3%[52] Acquisitions and Investments - The acquisition of EM4 was completed on March 18, 2024, for an aggregate purchase price of approximately $4.2 million in cash, with potential contingent payments of up to $6.75 million based on financial performance targets[46] - The total assets acquired from EM4 amounted to $11,016,000, with net assets acquired valued at $6,240,000 after assuming liabilities of $4,776,000[47] - The company recognized a gain of $1.5 million from the acquisition of EM4, attributed to the purchase price being lower than the estimated fair value of net assets acquired[47] Debt and Financing - The company issued $625.0 million aggregate principal amount of 1.25% Convertible Senior Notes due 2026, with interest payable semi-annually[77] - The net carrying amount of the 2026 Convertible Senior Notes was $183.236 million as of March 31, 2025, down from $201.015 million at the end of 2024[89] - The Company recognized $3.5 million in interest expense for the Senior Notes during the three months ended March 31, 2025[99] Legal and Regulatory Matters - The company intends to vigorously defend against ongoing legal matters, which are not expected to have a material adverse impact on financial results[168] Future Outlook - The company expects to continue incurring operating losses due to investments in product development and market expansion, indicating a focus on long-term growth strategies[31] - Research and Development (R&D) costs are expected to remain elevated as the company continues to invest in product enhancements and new technology development, leading to anticipated operating losses for the foreseeable future[209]